Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation
Treatment involves adults with certain forms of advanced stomach and oesophageal cancer
25th November 2022
Latest news
Depressive therapy Spravato demonstrates superior efficacy
Research supports use of Spravato nasal spray in adults with major depressive disorder
25th November 2022
Storm doses first patient with solid tumour drug candidate
Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development
24th November 2022
Multi-drug precision medicine cancer trial begins
Patients on the trial will have one of the particular genetic mutations among rare cancers
24th November 2022
Study brings personalised immunotherapy prescriptions closer
Research showed that prescribing based solely on levels of proteins present is unlikely to be suitable
23rd November 2022
Medicines for Malaria Venture and Novartis move to phase 3 trial
Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments
23rd November 2022
Takeda findings may minimise haemophilia treatment side effects
Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help treat patients
22nd November 2022
Turbine boosts AI platform to deliver cancer treatments
€20m financing will focus on treatment pathways, new partnerships and team expansion
22nd November 2022
Infex begins study of pseudomonas aeruginosa candidate RESP-X
Phase 1 research will evaluate tolerability and safety of therapy among healthy volunteers
21st November 2022
Iveric Bio receives new therapy designation for avacincaptad pegol
FDA grants status following primary endpoint data from pivotal trials treating geographic atrophy
21st November 2022
NICE recommends Sobi’s Doptelet to treat thrombocytopenia
Primary ITP is a rare autoimmune condition characterised by high platelet destruction
18th November 2022
Kidney Cancer UK receives commission from NICE
The charity commissioned a two-year service quality audit of over 18,000 kidney cancer patients
18th November 2022
Association of the British Pharmaceutical Industry lays down new antibiotics mission
The challenge of resistant infections will require new antibiotics according to the ABPI
17th November 2022
NICE recommends Pfizer’s Paxlovid on NHS
Therapy will be available on the NHS as a clinical treatment option for adults with COVID-19
17th November 2022
Evgen to investigate new SFX-01 tablet formulation
The therapy has the potential to treat neurological and oncological conditions
16th November 2022
